Nationwide Fund Advisors’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-474
| Closed | -$437K | – | 1859 |
|
|
2017
Q3 | $437K | Sell |
474
-11
| -2% | -$10.1K | ﹤0.01% | 2252 |
|
|
2017
Q2 | $453K | Buy |
485
+14
| +3% | +$13.1K | ﹤0.01% | 2241 |
|
|
2017
Q1 | $448K | Sell |
471
-30
| -6% | -$28.5K | ﹤0.01% | 2213 |
|
|
2016
Q4 | $402K | Sell |
501
-28
| -5% | -$22.5K | ﹤0.01% | 2292 |
|
|
2016
Q3 | $447K | Hold |
529
| – | – | ﹤0.01% | 2229 |
|
|
2016
Q2 | $436K | Buy |
529
+39
| +8% | +$32.1K | ﹤0.01% | 2221 |
|
|
2016
Q1 | $562K | Sell |
490
-15
| -3% | -$17.2K | ﹤0.01% | 2032 |
|
|
2015
Q4 | $630K | Buy |
505
+10
| +2% | +$12.5K | ﹤0.01% | 1987 |
|
|
2015
Q3 | $669K | Hold |
495
| – | – | ﹤0.01% | 1937 |
|
|
2015
Q2 | $892K | Buy |
495
+52
| +12% | +$93.7K | ﹤0.01% | 1928 |
|
|
2015
Q1 | $716K | Buy |
443
+30
| +7% | +$48.5K | ﹤0.01% | 2067 |
|
|
2014
Q4 | $314K | Sell |
413
-3
| -0.7% | -$2.28K | ﹤0.01% | 2435 |
|
|
2014
Q3 | $165K | Sell |
416
-8
| -2% | -$3.17K | ﹤0.01% | 2790 |
|
|
2014
Q2 | $256K | Buy |
424
+12
| +3% | +$7.25K | ﹤0.01% | 2627 |
|
|
2014
Q1 | $283K | Hold |
412
| – | – | ﹤0.01% | 2331 |
|
|
2013
Q4 | $268K | Buy |
412
+58
| +16% | +$37.7K | ﹤0.01% | 2544 |
|
|
2013
Q3 | $210K | Buy |
354
+12
| +4% | +$7.12K | ﹤0.01% | 2631 |
|
|
2013
Q2 | $108K | Buy |
+342
| New | +$108K | ﹤0.01% | 2775 |
|